January 4, 2021 -- InvestorsHub NewsWire -- via By Alex Carlson
-- The last half of 2020 was a banner year for penny stock
investors. There was no shortage of big runners
with Creative Medical Technologies (OTCMKTS:
CELZ), DSG Global (OTCMKTS:
DSGT), IQSTEL (OTCMKTS:
IQST), and Premier Products Group
(OTCMKTS:
PMPG) all closing 2020 strong.
In this article, we take a look at what’s happening with OTC
stocks CELZ, DSGT, IQST, and PMPG. We also give some insight on how
to trade penny stocks and what investors should look for when it
comes to the OTC Markets.
HOW TO TRADE PENNY STOCKS
First up, it’s important to understand that trading penny stocks
are not the same as trading blue chips. As we have stressed
repeatedly to our subscribers, the key to trading penny stocks is
finding momentum BEFORE it happens and then be patient.
We got our subscribers in early on TSNP,
which you can read our latest here,
and ENZC, which you can read
about here.
Now, when we say that we find momentum BEFORE it happens, we are
swing traders looking to position our subscribers BEFORE the move
happens. This is where the big money is made and why so many of our
subscribers are sitting on gains of
over 7750% in ENZC and over 18,650%
in TSNP.
If you want to day trade, this is not the place for you. If you
want to make a few hundred bucks and then lose a thousand dollars
the next day, we hear Tim Sykes has plenty of openings.
We always alert our subscribers first before we publish for our
regular readers. This is the value of having a subscription to
Insider Financial, which you can sign up for here. We
alert our subscribers with our best ideas before our regular
readers.
Insider Financial Talks OTC Stocks:
CELZ DSGT IQST PMPG
OTC STOCK #1: CELZ
CELZ was trading in the double zeroes and then really got moving
in the middle of December after announcing positive preclinical
data supporting the utilization of its ImmCelz® cell-based
immunotherapy for the treatment of stroke.
In an animal model of ischemia stroke, the middle cerebral
artery ligation model, administration of ImmCelz® resulted in a 34%
reduction in infarct volume, whereas control bone marrow
mesenchymal stem cells reduced infarct volume by 21%. Additionally,
improvements in functional recovery were observed using the Rotarod
test.
At 28 days after induction of stroke, the animals receiving
ImmCelz® had superior running time (92% of non-stroke controls)
compared to animals that received bone marrow mesenchymal stem
cells (73% of non-stroke control). Animals that received saline had
a running time that was 50% of non-stroke controls.
Further juicing the stock price was the ability of ImmCelz® to
reverse liver failure in the carbon tetrachloride preclinical model
of hepatocyte necrosis. These findings are the basis for a patent
filing covering various means of generating the ImmCelz® product in
a hepatoprotective specific manner. The Company has previously
reported that ImmCelz® is capable of treating animal models of
stroke, as well as inducing “immunological tolerance” in a model of
autoimmune rheumatoid arthritis.
To sum up CELZ, the company is a play on stem cells and its
technology works. To date, CELZ has demonstrated that ImmCelz® has
a therapeutic activity in stroke and liver failure. Liver failure
represents a significant unmet medical need and I am extremely
excited that ImmCelz® has the potential to help the numerous
patients on the liver transplant waiting list who currently have no
other option.
OTC STOCK #2: DSGT
On October 12, we wrote this article on DSGT saying that it was an EV play
with huge upside. DSGT closed at $.15 that day.
While it took over 10 months, DSGT turned into a 10-bagger for
our readers and subscribers that had the patience to stay in. We
pounded the table on DSGT for all those willing to listen. We
said:
DSGT is now a pure-play on electric vehicles trading under $1.
We know of no other pure-play EV stock trading under $1. We have
seen the moves this year in Tesla, NIO, Workhorse, and Lordstown, DSGT looks to be the next
EV rocket.
DSGT has been a steady climber as the company executes its
business plan. On December 22nd, Imperium Motors announced the
receipt of three shipments totaling 73 electric vehicles,
representing the first containers of Jonway, Skywell, and Rumble
Motors electric vehicles arriving at its location in Fairfield
California.
The current shipment included the high-speed Skywell ET-5 SUVs,
multiple Jonway scooters, a variety of 3- and 4-wheel cars, vans,
trucks, and a large container of Rover electric bike products and
other Rumble Motors models, which will be shown in the Company’s
Experience Center.
DSGT is now positioned to start off 2021 strong with vehicles
in-house to sell.
“With the arrival of these vehicles to our facility, we are now
officially on track to launch our 2021 Imperium Motors sales
efforts,” commented Rick Curtis, President of Imperium Motor Corp
“We have long spoken of the excellent quality and value of these
vehicles as well as their value to the environment. Importantly,
they are a key component of our projected 2021 revenue, and we
anticipate a strong start to the New Year.”
OTC STOCK #3: IQST
IQST is another OTC stock that we profiled back in October, but
took some time to pay off. We said that IQST was an undervalued
opportunity, which you can read here.
IQST was trading around $.06 at the time.
We believe IQST still has more room to run as its current market
cap is only $18.7 million. Year to date revenue is now $39,725,507
putting the company well on track to exceed its $42 million revenue
projection for 2020.
IQST is also making shareholder-friendly moves after converting
21 million common shares held among the CEO, CFO, and chief
commercial officer into Series B preferred shares, effectively
reducing the outstanding share count by more than 22%. These Class
B preferred shares have a one-year lock-up, and upon conversion,
management has opted for a one-year leak out on the shares into the
outstanding share count.
Back in October, Goldman Small Cap Research issued a research
report with a $.54 a share price target on IQST.
OTC STOCK #4: PMPG
PMPG is running as the company is a play on autonomous driving.
Its road pavement markers (Road Turtles) have the ability to
transmit data and transform a municipality into a Smart City. Every
road turtle on the road can house up to 7 sensors to interact
(transmit data) with automobiles. Sensors such as GPS, temperature,
movement, environment detection, humidity, and environmental to
name a few.
PMPG has completed the due diligence process of its SmartRoad
Turtle, LLC (SRT) joint venture project. SmartRoad Turtle, LLC,
expects to have a Letter of Intent for manufacturing and
distribution to be signed with Ennis-Flint in a few weeks. Ennis-Flint is a
global manufacturer of coatings with a broad portfolio of road
pavement marking products, thermoplastics, advanced traffic
technologies, and intelligent transportation systems.
Ennis-Flint is a really big deal. This will give PMPG and its
SmartRoad Turtle global reach. If the company can execute and
complete its fund-raising, there’s a lot more room PMPG can
run.
BOTTOM LINE
These four penny stocks are hot right now. There are always
opportunities on the OTC and it’s our job to find the bull markets.
Huge gains can be made in such a short amount of time.
For those that missed out on the recent run in these four OTC
stocks, our best advice is to be patient and throw bids in below
the market. Buying dips and selling rips as swing trades remains
the best strategy in these markets.
Remember, all it takes is one or two to become a TSNP or an ENZC
and you’re set to buy a new house and not just make a rent or
mortgage payment.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO
LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT
WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN
FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any
of the securities mentioned. We wrote this article ourselves
and it expresses our own opinions. We are not receiving
compensation for it. We have no business relationship with any
company whose stock is mentioned in this article. Insider Financial
is not an investment advisor and does not provide investment
advice. Always do your own research and make your own investment
decisions. This article is not a solicitation or recommendation to
buy, sell, or hold securities. This article is meant for
informational and educational purposes only and does not provide
investment advice.
Image by Matan Ray
Vizel from Pixabay
RELATED ITEMS:FEATURED, OTCMKTS:CELZ, OTCMKTS:DSGT, OTCMKTS:IQST, OTCMKTS:PMPG
Source -Alex Carlson : https://insiderfinancial.com/4-otc-stocks-on-the-move-celz-dsgt-iqst-pmpg/180804/
Premier Products (CE) (USOTC:PMPG)
Historical Stock Chart
From Nov 2024 to Dec 2024
Premier Products (CE) (USOTC:PMPG)
Historical Stock Chart
From Dec 2023 to Dec 2024